» Articles » PMID: 33498509

Comparison of Genetically Engineered Immunodeficient Animal Models for Nonclinical Testing of Stem Cell Therapies

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2021 Jan 27
PMID 33498509
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

For the recovery or replacement of dysfunctional cells and tissue-the goal of stem cell research-successful engraftment of transplanted cells and tissues are essential events. The event is largely dependent on the immune rejection of the recipient; therefore, the immunogenic evaluation of candidate cells or tissues in immunodeficient animals is important. Understanding the immunodeficient system can provide insights into the generation and use of immunodeficient animal models, presenting a unique system to explore the capabilities of the innate immune system. In this review, we summarize various immunodeficient animal model systems with different target genes as valuable tools for biomedical research. There have been numerous immunodeficient models developed by different gene defects, resulting in many different features in phenotype. More important, mice, rats, and other large animals exhibit very different immunological and physiological features in tissue and organs, including genetic background and a representation of human disease conditions. Therefore, the findings from this review may guide researchers to select the most appropriate immunodeficient strain, target gene, and animal species based on the research type, mutant gene effects, and similarity to human immunological features for stem cell research.

Citing Articles

Advances and applications of genome-edited animal models for severe combined immunodeficiency.

Zheng X, Huang C, Yan S, Rong M Zool Res. 2025; 46(1):249-260.

PMID: 39846200 PMC: 11891005. DOI: 10.24272/j.issn.2095-8137.2024.195.


Animal models for transplant immunology: bridging bench to bedside.

Kang M, Park H, Kim K, Choi D Clin Transplant Res. 2024; 38(4):354-376.

PMID: 39233453 PMC: 11732767. DOI: 10.4285/ctr.24.0029.


Synergistic Promoting Effects of X-Linked Inhibitor of Apoptosis Protein and Matrix on the In Vitro Follicular Maturation of Marmoset Follicles.

Kim Y, Yun J, Kim S, Kim H, Kang B, Ku S Tissue Eng Regen Med. 2021; 19(1):93-103.

PMID: 34741748 PMC: 8782987. DOI: 10.1007/s13770-021-00387-4.

References
1.
Tanaka M, Kuramochi M, Nakanishi S, Kuwamura M, Kuramoto T . Rat polyomavirus 2 infection in a colony of X-linked severe combined immunodeficiency rats in Japan. J Vet Med Sci. 2018; 80(9):1400-1406. PMC: 6160877. DOI: 10.1292/jvms.18-0107. View

2.
Young S, Schilling A, Skeans S, Ritacco G . Short duration anaesthesia with medetomidine and ketamine in cynomolgus monkeys. Lab Anim. 2000; 33(2):162-8. DOI: 10.1258/002367799780578363. View

3.
Fan J, Kitajima S, Watanabe T, Xu J, Zhang J, Liu E . Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine. Pharmacol Ther. 2014; 146:104-19. PMC: 4304984. DOI: 10.1016/j.pharmthera.2014.09.009. View

4.
Nelms K, Keegan A, Zamorano J, Ryan J, Paul W . The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999; 17:701-38. DOI: 10.1146/annurev.immunol.17.1.701. View

5.
Gilmore K, Greer K . Why is the dog an ideal model for aging research?. Exp Gerontol. 2015; 71:14-20. DOI: 10.1016/j.exger.2015.08.008. View